首页 | 本学科首页   官方微博 | 高级检索  
检索        

COPD患者血清hepcidin、sTfR测定在贫血并发症中的应用价值研究
引用本文:高炎超,秦茵茵.COPD患者血清hepcidin、sTfR测定在贫血并发症中的应用价值研究[J].中国实验诊断学,2012(9):1603-1606.
作者姓名:高炎超  秦茵茵
作者单位:1. 南方医科大学附属何贤纪念医院 呼吸内科,广东 番禺511400
2. 广州医学院第一附属医院 呼吸内科,广东 广州510120
基金项目:国家自然科学基金(81100035)
摘    要:目的检测慢性阻塞性肺疾病(COPD)伴发贫血患者血清中铁调节素(hepcidin)和血清转铁蛋白受体(ser-um transfer-ring receptor,sTfR)的表达变化,探讨其在COPD相关性贫血中的作用。方法收集我院2008年12月~2010年12月收治的COPD患者104例,其中COPD贫血患者24例,COPD非贫血患者80例,另取在本院体检中心健康体检者30例作为对照组。ELISA检测受试者血清hepcidin和sTfR的表达水平。结果 COPD患者中贫血的发病率为23.1%(24/104)。对照(A)组、COPD(B)组和COPD合并贫血(C)组hepcidin的表达水平分别为21.33±5.26、29.46±8.57和41.02±11.34ng/mL,各组间存在显著性差异(F=8.64,P<0.05);A、B和C组中sTfR的表达水平分别为19.21±3.77、27.68±5.72和37.94±8.61nmol/L,各组间亦存在显著性差异(F=7.58,P<0.05);其中C组中hepcidin和sTfR的表达水平均显著高于B组(P<0.05)。轻度、中度和重度组COPD伴发贫血患者hepci-din的表达水平分别为35.42±6.24、42.31±7.44和51.23±12.144ng/mL,各组间存在显著性差异(F=7.64,P<0.05);上述各组中sTfR的表达水平分别为32.27±5.68、40.74±6.46和47.32±9.84nmol/L,各组间亦存在显著性差异(F=7.42,P<0.05)。相关性分析显示血清hepcidin表达水平与患者的血红蛋白水平呈负相关(r=-0.574,P<0.05),血清sTfR表达水平亦与患者的血红蛋白水平呈负相关(r=-0.535,P<0.05),血清hepcidin和sTfR的表达水平呈正相关(r=0.686,P<0.01)。结论 COPD患者hepcidin的升高所导致的机体可利用铁减少可能是COPD相关性贫血的主要成因,Hepcidin有望成为COPD相关性贫血的一个新的治疗靶点,或者是疗效的监控指标。。

关 键 词:慢性阻塞性肺疾病  贫血  铁调节素  血清转铁蛋白受体

The detection of hepcidin and sTfR in COPD with anemia patients and its clinic significance
GAO Yan-chao,QIN Yin-yin.The detection of hepcidin and sTfR in COPD with anemia patients and its clinic significance[J].Chinese Journal of Laboratory Diagnosis,2012(9):1603-1606.
Authors:GAO Yan-chao  QIN Yin-yin
Institution:1.Southern Medical University Brian Ho Memorial Hospital respiratory medicine in Panyu,Guangdong 511400;2.Guangzhou Medical College First Affiliated Hospital of Respiratory Medicine,Guangzhou 510120)
Abstract:Objective To observe the clinical significance of hepcidin and serum transfer-ring receptor(sTfR) in patients with chronic obstructive pulmonary disease(COPD) related anemia.Methods A total of 104 patients with COPD were enrolled in this study.24 COPD patients were diagosed as anemia.30 healthy person were used as a normal control.The expression of hepcidin and sTfR in serum was detected by ELISA analysis.Results The prevalence of anemia COPD was 23.1%(24/104).The level of hepcidin in serum was 21.33±5.26,29.46±8.57,and 41.02±11.34 ng/mL in control(A)group,COPD(B)group and COPD associated anema(C)group,respectively.Significant difference of hepcidin level was found between the three groups(F=8.64,P〈0.05).The level of sTfR in serum was 19.21±3.77,27.68±5.72,and 37.94±8.61 nmol/L in A,B,and C group,respectively.Significant difference of hepcidin level was found between the three groups(F=7.58,P〈0.05).The expression of hepcidin in low,medium,and high anema patients were 35.42±6.24,42.31±7.44,and 51.23±12.144 ng/mL,respectively.Significant difference was found between the three groups(F=7.64,P〈0.05).The expression of sTfR in low,medium,and high anema patients were 32.27±5.68,40.74±6.46,47.32±9.84 nmol/L,respectively.Significant difference was found between the three groups(F=7.42,P〈0.05).The level of hepcidin in serum was negatively related with Hb level(r=-0.574,P〈0.05).The level of sTfR in serum was also negatively related with Hb level(r=-0.535,P〈0.05).The level of hepcidin was positively related with sTfR level(r=0.686,P〈0.05).Conclusion The high-level expression of hepcidin play a key role in the development of COPD-related anemia.Hepcidin may be used as a new target to treat COPD patients with anemia.
Keywords:chronic obstructive pulmonary disease(COPD)  anemia  hepcidin  serum transfer-ring receptor(sTfR)
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号